Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I hope there is some agreement between PTSC and S&L ...

From the divy PR: "PTSC today announced that it will issue a cash dividend of $0.02 per share of common stock for shareholders and qualified warrant holders of record as of March 6, 2007. The dividend is payable April 9, 2007."

qualified warrant holders.

SGE

Share
New Message
Please login to post a reply